C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
VREOF US MSO

Vireo Growth

OTCMKTS · VREOF

Cannabis operator with dispensaries and cultivation across multiple US states.

Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
59/100 composite
Fundamentals88
Regulatory53
Market40
Editorial30
Composite · trailing 12 months

The model outputs a Neutral rating for Vireo Growth, scoring 59/100 at conviction 2 of 5. Weights are locked at 35 percent fundamentals, 25 percent regulatory, 25 percent market, and 15 percent editorial, and each pillar is broken out for direct review. The fundamentals pillar contributes the largest share at 88, pulling the composite into the middle of the band. Opposite that, editorial prints only 30, and is what keeps the rating anchored where it is.

Pillar-level, the record reads as reported revenue growth of 333.5 percent year over year, an operating margin of 16.7 percent, a filing cadence of 1 regulator events in the trailing 90 days. Each of those data points tethers the Neutral conclusion to observable evidence. Inputs are limited to primary regulatory filings, licensed fundamentals data, and institutional pricing feeds, plus a density read from CIN newsroom coverage. The rating enables direct comparison across the 336 tickers in the CIN coverage universe on a consistent, deterministic basis, and refreshes on a scheduled cadence tied to the primary-source ingest cycle.

The clearest catalyst is the next quarterly print. Fundamentals contribute 88 of the composite, and either an acceleration in top-line growth or a stabilization of the operating margin would move the score higher; a deterioration on either would compress it.

Scored: 2026-07-14Valid through: 2026-08-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
Headquarters
207 SOUTH 9TH STREET, MINNEAPOLIS, MN, 55402
Phone
604-617-5421
CEO
John Mazarakis
CFO
Tyson Macdonald
SEC CIK
1771706
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$490.7M
Enterprise value
$769.4M
Price to book
1.67
Price to sales
1.40
EV / EBITDA
40.49
Revenue (TTM)
$350.5M
Gross profit (TTM)
$174.0M
EBITDA
$45.2M
Operating margin
16.7%
Profit margin
-23.4%
Rev growth YoY
333.5%
Return on equity
-47.5%
Return on assets
2.6%
EPS (TTM)
$-2.70
EPS est. current year
$0.20
Wall St. target price
$45.00
Shares outstanding
48.5M
Insider ownership
33.2%
Institutional ownership
7.8%
Beta
0.07
Full-time employees
520
GICS sector
Healthcare
GICS industry
Drug Manufacturers - Specialty & Generic
Filings & DisclosuresPrimary sources
Annual report
Latest 10-K
Proxy statement
Latest DEF 14A
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for Vireo Growth (VREOF)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Vireo Growth (VREOF), a cannabis-sector equity listed on OTCMKTS in the US MSO category. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Event-Driven Opportunity. Setup improving. Long-term outperformer detected. (3 bullish signals, 1 bearish signal.)

Cannabis operator with dispensaries and cultivation across multiple US states.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for VREOF are maintained by Cannabis Investor News and refreshed throughout the trading day.